glp-1 hypothalamus Glucagon‐like peptide‐1 (GLP‐1) signalling in the brain: From neural circuits and metabolism to therapeutics - Kabahizi - 2022 - British Journal of Pharmacology GLP-1 in addiction medicine: GLP-1

Quality control is clearly a priority

Olmos, Brenda

Aqualyx is a CE-marked injectable fat dissolver based on deoxycholate, a bile-salt compound, combined with phosphatidylcholine

Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases

The 2026 ADA Standards of Care, released at the meeting, formally elevated cardiovascular and kidney risk reduction to a co-primary treatment goal alongside blood sugar control ending decades of practice in which A1C was the dominant benchmark

For cell number measurements in 24-well plates, unstained plates were scanned in bright field using SparkCyto (Tecan) at 37 C under 5% CO 2